Goat F(ab')2 anti-Human IgM Heavy Chain Secondary Antibody [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-75027
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunomicroscopy
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
1.5 mg/ml
Product Specifications
Immunogen
Purified Human IgM, Mu chain
Reactivity Notes
Based on IEP, no reactivity is observed to non-immunoglobulin human serum proteins and light chains on all human immunoglobulins
Specificity
Based on IEP, this antibody reacts with heavy mu chains on human IgM
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Description
Purity > 90% based on SDS-PAGE Small amounts of intact IgG may be present. . Goat serum was obtained from healthy animals of US origin and under the care of a registered veterinarian.
Applications for Goat F(ab')2 anti-Human IgM Heavy Chain Secondary Antibody [FITC]
Application
Recommended Usage
Flow Cytometry
1:20-1:2000
Immunomicroscopy
1:20-1:2000
Application Notes
This conjugate is suitable for immunomicroscopy and flow cytometry.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
10 mM Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 1 % (w/v) BSA, Protease/IgG free
Preservative
0.05% Sodium Azide
Concentration
1.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: IgM Heavy Chain
Alternate Names
Constant region of heavy chain of IgM, Ig Mu Chain C Region BOT, Ig Mu Chain C Region GAL, Ig Mu Chain C Region OU, immunoglobulin heavy constant mu, Immunoglobulin mu chain
Gene Symbol
IGHM
Additional IgM Heavy Chain Products
Product Specific Notices for Goat F(ab')2 anti-Human IgM Heavy Chain Secondary Antibody [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Secondary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...